Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial
Following publication of the original article [1], we have been notified that the tagging of one of the author names was done incorrectly in the XML version of the paper. Original and corrected tagging can be seen below.
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-06-01
|
| Series: | Trials |
| Online Access: | http://link.springer.com/article/10.1186/s13063-019-3519-9 |
| _version_ | 1818451897414057984 |
|---|---|
| author | Thomas G. de Leeuw Laura Mangiarini Rebecca Lundin Florentia Kaguelidou Tjitske van der Zanden Oscar Della Pasqua Dick Tibboel Adriana Ceci Saskia N. de Wildt on behalf of the GAPP consortium |
| author_facet | Thomas G. de Leeuw Laura Mangiarini Rebecca Lundin Florentia Kaguelidou Tjitske van der Zanden Oscar Della Pasqua Dick Tibboel Adriana Ceci Saskia N. de Wildt on behalf of the GAPP consortium |
| author_sort | Thomas G. de Leeuw |
| collection | DOAJ |
| description | Following publication of the original article [1], we have been notified that the tagging of one of the author names was done incorrectly in the XML version of the paper. Original and corrected tagging can be seen below. |
| first_indexed | 2024-12-14T21:14:30Z |
| format | Article |
| id | doaj.art-efe2cb190843470f8dcd3b97824b88b0 |
| institution | Directory Open Access Journal |
| issn | 1745-6215 |
| language | English |
| last_indexed | 2024-12-14T21:14:30Z |
| publishDate | 2019-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj.art-efe2cb190843470f8dcd3b97824b88b02022-12-21T22:47:09ZengBMCTrials1745-62152019-06-012011110.1186/s13063-019-3519-9Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trialThomas G. de Leeuw0Laura Mangiarini1Rebecca Lundin2Florentia Kaguelidou3Tjitske van der Zanden4Oscar Della Pasqua5Dick Tibboel6Adriana Ceci7Saskia N. de Wildt8on behalf of the GAPP consortiumDepartment of Anesthesia and Pain Medicine, Erasmus MC-Sophia Children’s HospitalConsorzio per Valutazione Biologiche e FarmacologicheFondazione Penta OnlusDepartment of Pediatric Pharmacology and Pharmacogenetics, AP-HP, Hôpital Robert DebréIntensive Care and Department of Paediatric Surgery, Erasmus MC-Sophia Children’s HospitalUniversity College LondonIntensive Care and Department of Paediatric Surgery, Erasmus MC-Sophia Children’s HospitalConsorzio per Valutazione Biologiche e FarmacologicheIntensive Care and Department of Paediatric Surgery, Erasmus MC-Sophia Children’s HospitalFollowing publication of the original article [1], we have been notified that the tagging of one of the author names was done incorrectly in the XML version of the paper. Original and corrected tagging can be seen below.http://link.springer.com/article/10.1186/s13063-019-3519-9 |
| spellingShingle | Thomas G. de Leeuw Laura Mangiarini Rebecca Lundin Florentia Kaguelidou Tjitske van der Zanden Oscar Della Pasqua Dick Tibboel Adriana Ceci Saskia N. de Wildt on behalf of the GAPP consortium Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial Trials |
| title | Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial |
| title_full | Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial |
| title_fullStr | Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial |
| title_full_unstemmed | Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial |
| title_short | Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial |
| title_sort | correction to gabapentin as add on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years evaluation of the safety pharmacokinetics and efficacy of a new gabapentin liquid formulation study protocol for a randomized controlled trial |
| url | http://link.springer.com/article/10.1186/s13063-019-3519-9 |
| work_keys_str_mv | AT thomasgdeleeuw correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT lauramangiarini correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT rebeccalundin correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT florentiakaguelidou correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT tjitskevanderzanden correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT oscardellapasqua correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT dicktibboel correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT adrianaceci correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT saskiandewildt correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial AT onbehalfofthegappconsortium correctiontogabapentinasaddontomorphineforsevereneuropathicormixedpaininchildrenfromage3monthsto18yearsevaluationofthesafetypharmacokineticsandefficacyofanewgabapentinliquidformulationstudyprotocolforarandomizedcontrolledtrial |